BillionToOne, Inc.·4

Jul 15, 4:38 PM ET

ten Bosch John Roderick 4

4 · BillionToOne, Inc. · Filed Jul 15, 2026

Research Summary

AI-generated summary of this filing

Updated

BillionToOne (BLLN) SVP John R. ten Bosch Sells 4,251 Shares

What Happened

  • John R. ten Bosch, Senior Vice President of Laboratory Operations at BillionToOne (BLLN), reported three sales on 2026-07-13, disposing of a total of 4,251 shares (3 x 1,417 shares) at $125.46 per share. Each block generated $177,777, for aggregate proceeds of approximately $533,331. The transactions are reported as open-market or private sales (code S).

Key Details

  • Transaction date: July 13, 2026
  • Price per share: $125.46
  • Shares sold: 3 transactions of 1,417 shares each; total 4,251 shares
  • Total proceeds: ~$533,331 (3 × $177,777)
  • Shares owned after transaction: Not specified in the provided Form 4
  • Filing: Form 4 filed July 15, 2026 (two business days after the trades)
  • Footnote: Transactions were made under a Rule 10b5-1 trading plan adopted March 6, 2026

Context

  • These are sales (not purchases) and were executed under a pre-established 10b5-1 plan, which typically indicates pre-planned, systematic disposition rather than an opportunistic trade. The filing appears timely (filed within the usual two-business-day window for Form 4).

Insider Transaction Report

Form 4
Period: 2026-07-13
ten Bosch John Roderick
SVP of Laboratory Operations
Transactions
  • Sale

    Class A Common Stock

    [F1]
    2026-07-13$125.46/sh1,417$177,77732,135 total
  • Sale

    Class A Common Stock

    [F1]
    2026-07-13$125.46/sh1,417$177,77730,718 total
  • Sale

    Class A Common Stock

    [F1]
    2026-07-13$125.46/sh1,417$177,77729,301 total
Footnotes (1)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-07-15

Documents

1 file
  • 4
    wk-form4_1784147901.xmlPrimary

    FORM 4